Nivi Development P/S is a Danish partnerselskab (P/S) engaged in research and development activities within the broader life sciences and chemical value chain. Operating under Danish corporate law, the company focuses on advancing innovative technologies from early-stage concepts toward applied development.
Its work typically spans product and process development, formulation, and translational R&D in regulated environments, carried out in collaboration with industry and public-sector partners. Nivi Development emphasizes scientific rigor, quality, and compliance to support the progression of promising concepts toward validation and potential market readiness.
The EU funds next-gen flu vaccines to enhance protection, speed up development, and improve pandemic readiness through pre-commercial procurement.
